Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Preventing Collapse in Osteonecrosis of the Femoral Head
NCT00939900Phase 3Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jul 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteonecrosis of the femoral head (ONFH), sponsored by Seoul National University Bundang Hospital. Started Jul 2009; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on NCT00939900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939900.